Clinical Trial Update: Post-approval Study of The Glaukos® iStent® Trabecular Micro-bypass Stent: Extended Follow-up of the Premarket Cohort

View source ↗

Summary

This post-approval study provides extended follow-up data on the iStent trabecular micro-bypass stent in patients with primary open-angle glaucoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Open-angle Glaucoma

Drugs mentioned

• iStent

Snippet

Sponsor: Glaukos Corporation | Conditions: Primary Open Angle Glaucoma | Status: COMPLETED | Results posted: 2016-04-15